Example: Heart Attack

Search clinical trials for: Adrenergic alpha-1 Receptor Antagonists

Total 553 results

    • NCT04365257
      Recruiting
      Prazosin to Prevent COVID-19 (PREVENT-COVID Trial)
      Conditions: COVID-19
    • NCT00762710
      Completed
      Study of the Medication Prazosin for Alcohol Dependence
      Conditions: Alcoholism
    • NCT00880997
      Completed
      The Efficacy of Doxazosin for Cocaine Users
      Conditions: Cocaine Dependence
    • NCT00240227
      Terminated
      Prazosin for ETOH or Cocaine Craving
      Conditions: Alcoholism; Cocaine Dependence
    • NCT04491526
      Recruiting
      Study to Prevent Postoperative Urinary Retention
      Conditions: Urinary Retention; Inguinal Hernia
    • NCT01953432
      Completed
      Pharmacogenetic Trial of Doxazosin for Treatment of Cocaine Abuse
      Conditions: Cocaine Dependence
    • NCT02322047
      Completed
      Prazosin and Naltrexone (PaN) Study for Veterans With Alcohol Use Disorders
      Conditions: Alcohol Use Disorder; Posttraumatic Stress Disorder (PTSD)
    • NCT00824200
      Unknown status
      Behavior and Exercise Versus Drug Treatment in Men With Nocturia (BEDTiMe)
      Conditions: Nocturia
    • NCT01621165
      Withdrawn
      Prazosin as an Antimanic Agent in Severe Mania or Mixed States
      Conditions: Bipolar, Mania; Bipolar, Mixed State
    • NCT00295555
      Completed
      Doxazosin Effects on ABPM in Hypertensive Patients With Diabetic Nephropathy
      Conditions: Diabetes Mellitus; Essential Hypertension; Renal Failure
    • NCT02817360
      Recruiting
      NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients
      Conditions: Heart Diseases; Diabetes Mellitus, Type 2
    • NCT03144596
      Completed
      The Effects of α-adrenergic Receptor Antagonists on Choroid and Pupil
      Conditions: Benign Prostatic Hyperplasia; Pupil Anomaly; Choroid Disease
    • NCT04359979
      Recruiting
      Tamsulosin for Thyroid Lid Retraction
      Conditions: Thyroid Eye Disease; Eyelid Diseases
    • NCT04386317
      Recruiting
      Terazosin Effect on Cardiac Changes in Early Parkinson's Disease
      Conditions: REM Sleep Behavior Disorder; Pre-motor Parkinson's Disease; Symptomatic Parkinson Disease
    • NCT01834729
      Completed
      Effects of Alpha-1 Antagonist, Stress and Relaxation on Anorectal Functions
      Conditions: Constipation
    • NCT02966340
      Completed
      Repurposing alpha1 Noradrenergic Antagonists for Alcoholism Treatment
      Conditions: Alcoholism
    • NCT02266537
      Completed
      Study to Assess the Influence of Three Different α-antagonists and Placebo on the Extent of Weekly Phenylephrine-induced Mydriasis at Three Different Concentrations of Phenylephrine in Healthy Male Volunteers
      Conditions: Healthy
    • NCT01259531
      Completed
      Study of a α1A Adrenoceptor Selective Antagonist Silodosin to Treat Severe Benign Prostatic Hyperplasia(BPH)
      Conditions: Benign Prostatic Hyperplasia
    • NCT01437046
      Completed
      Doxazosin an a1 Antagonist for Alcohol Dependence
      Conditions: Alcohol Dependence; Anxiety
    • NCT01178138
      Completed
      Monoamine Antagonist Therapies for Methamphetamine Abuse Prazosin
      Conditions: Continuous Methamphetamine Abuse
    • NCT00730418
      Completed
      Effects of Chronic Use of Doxazosin in Men With Benign Prostatic Hyperplasia
      Conditions: Benign Prostatic Hyperplasia
    • NCT04371757
      Recruiting
      Influence of the Autonomic Nervous System in Response to Exercise in Hypertensive Individuals
      Conditions: Autonomic Nervous System; Hypertension
    • NCT03576664
      Completed
      Effects of Sleep Deprivation and Adrenergic Inhibition on Glymphatic Flow in Humans
      Conditions: Sleep Deprivation; Sleep Wake Disorders; Sleep
    • NCT02279615
      Unknown status
      Efficacy And Safety Of Combination Therapy For Treatment Of Overactive Bladder In Male Patients With Benign Prostatic Hyperplasia.
      Conditions: Overactive Bladder; Benign Prostatic Hyperplasia
    • NCT00793819
      Completed
      A Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia
      Conditions: Nocturia; Prostatic Hyperplasia
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations